(Q35124738)

6 August 2017

Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin (English)

1 reference

6 August 2017

0 references

1 reference

1 reference

angiogenesis inhibitor

1 reference

Brian Hutzen

1

1 reference

6 August 2017

Hemant Kumar Bid

2

1 reference

6 August 2017

Peter J Houghton

3

1 reference

6 August 2017

Christopher R Pierson

4

1 reference

6 August 2017

Kimerly Powell

5

1 reference

6 August 2017

Anna Bratasz

6

1 reference

6 August 2017

Corey Raffel

7

1 reference

6 August 2017

Adam W Studebaker

8

1 reference

6 August 2017

language of work or name

English

0 references

publication date

19 March 2014

1 reference

6 August 2017

1 reference

6 August 2017

14

1 reference

6 August 2017

206

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-14-206

6 August 2017

0 references

cites work

Anti-angiogenesis therapy in cancer: current challenges and future perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Adherens junction protein nectin-4 is the epithelial receptor for measles virus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Treatment of medulloblastoma with a modified measles virus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Lister strain of vaccinia virus armed with endostatin-angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

The measles virus replication cycle.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Antiangiogenic strategies in medulloblastoma: reality or mystery.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Prostate-restricted replicative adenovirus expressing human endostatin-angiostatin fusion gene exhibiting dramatic antitumor efficacy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

RNA polymerase II-controlled expression of antigenomic RNA enhances the rescue efficacies of two different members of the Mononegavirales independently of the site of viral genome replication

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

CD46 represents a target for adenoviral gene therapy of malignant glioma.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Oncolytic herpesvirus with secretable angiostatic proteins in the treatment of human lung cancer cells.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Endostatin's antiangiogenic signaling network

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Long-term neuro-endocrine sequelae after treatment for childhood medulloblastoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Tumor angiogenesis: therapeutic implications

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Medulloblastoma: signalling a change in treatment

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-206

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-206

Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-206

Therapeutic potential of oncolytic measles virus: promises and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-206

Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-206

Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-206

Angiogenesis in brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-206

Bevacizumab and irinotecan in the treatment of children with recurrent/refractory medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-206

Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-206

Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-206

Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-206

Targeted delivery of an antibody-mutant human endostatin fusion protein results in enhanced antitumor efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-206

Oncolytic measles virus targets high CD46 expression on multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-206

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-206

Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995427

The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3

27 September 2018

1 reference

12 December 2020

Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue

1 reference

12 December 2020

Cancer therapy. Setbacks for endostatin

1 reference

12 December 2020

Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors

1 reference

12 December 2020

Angiostatin: A Circulating Endothelial Cell Inhibitor That Suppresses Angiogenesis and Tumor Growth

1 reference

12 December 2020

Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A

1 reference

12 December 2020

Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-14-206

1 reference

Dimensions Publication ID

6 August 2017

1017989229

0 references

Fatcat ID

release_tfjp3p7ydncl7gv3acvgzuodu4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tfjp3p7ydncl7gv3acvgzuodu4

24 November 2022

mapped directly with Wikidata item

PMCID

3995427

1 reference

6 August 2017

1 reference